Karen Chee is a Hematologist in San Mateo, California. Dr. Chee is highly rated in 37 conditions, according to our data. Her top areas of expertise are Febrile Neutropenia, Non-Hodgkin Lymphoma, Agranulocytosis, and Chronic Familial Neutropenia. Dr. Chee is currently accepting new patients.

Dr. Bradley Ekstrand is a genitourinary oncologist who has particular interest and expertise in treating patients with lymphoma and genitourinary cancers. His background in the molecular biology of cancer gives him a unique perspective, combining a scientist's view of disease with a doctor's expertise, to bring the best care to patients with cancer. Ekstrand earned his medical degree from Yale School of Medicine, where he also completed a doctorate in cancer biology. During his doctoral studies, he worked in the lab of acclaimed cancer genetics researcher Dr. Eric Fearon, where he focused on tumor suppressor genes. He completed a residency in internal medicine at Mount Sinai Medical Center and a fellowship in medical oncology at Stanford University School of Medicine. During his fellowship, he worked extensively in lymphoma with Drs. Sandra Horning and Gilbert Chu. Ekstrand is a member of the American Society of Clinical Oncology and Association of Northern California Oncologists, where he serves as vice president. Through his work with these organizations, he advocates for high-quality cancer care for all patients. A native of Boulder, Colorado, Ekstrand enjoys outdoor recreation, particularly alpine skiing, swimming and long-distance running. Outside of work, he devotes most of his time to family activities with his wife and three children. An avid sports fan, he follows Stanford athletics, European soccer leagues and the Denver Broncos. Dr. Ekstrand is highly rated in 30 conditions, according to our data. His top areas of expertise are Follicular Lymphoma, Familial Prostate Cancer, Small Lymphocytic Lymphoma (SLL), and Large-Cell Immunoblastic Lymphoma.

Dr. Kent Adler is an oncologist experienced in treating a variety of cancers, with particular expertise in lung and breast cancer. He believes three pillars form the strongest foundation to fight cancer: knowledge, communication and heart. Adler's research focuses on developing new therapies for lung cancer. Adler earned his medical degree from UCSF. He completed a residency in internal medicine at New York – Presbyterian/Weill Cornell Medical Center and a fellowship in medical oncology at Stanford University School of Medicine. A longtime advocate of multidisciplinary clinics for managing cancer, he co-founded one of the first multidisciplinary clinics for lung cancer on the West Coast while a faculty member at Stanford. Throughout his career, Adler has served in leadership positions, including as a board member of the Mills Peninsula Medical Group and Association of Northern California Oncologists. In his free time, Adler enjoys traveling, skiing and hiking with his wife, also a doctor, and their two adult children. A native of the Bay Area, he also loves the San Francisco Giants and almost anything related to baseball. Dr. Adler is highly rated in 20 conditions, according to our data. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Paget Disease of the Breast, and Large-Cell Immunoblastic Lymphoma.

Hematology (Board Certified) Accepting new patients. Dr. Kao is highly rated in 17 conditions, according to our data. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Essential Thrombocythemia, and Pleuropulmonary Blastoma.

Robert Weber is a Hematologist and an Oncologist in Daly City, California. Dr. Weber is highly rated in 36 conditions, according to our data. His top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Familial Colorectal Cancer, and Colorectal Cancer. Dr. Weber is currently accepting new patients.

Jennifer Brown is an Oncologist in San Mateo, California. Dr. Brown is highly rated in 5 conditions, according to our data. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer.

Dr. Elham Vosoughi is a hematologist-oncologist who cares for patients with breast cancer. Vosoughi's research focuses on designing and conducting clinical trials for early stage and metastatic breast cancer. Vosoughi earned her medical degree at the Mazandaran University of Medical Sciences in Iran. She completed a residency in internal medicine at San Joaquin General Hospital and a fellowship in hematology-oncology at the University of California, Irvine School of Medicine. Outside of work, Vosoughi is an avid traveler who has visited more than 20 countries and enjoys cross-country road trips and RV camping. She also practices martial arts, and holds a brown belt in Shito-Ryu karate. Her top areas of expertise are Melanoma, HER-2 Positive Breast Cancer, Breast Cancer, and Kaposi Sarcoma.

Julian Mclain is a Hematologist in San Mateo, California. His top areas of expertise are Multicentric Castleman Disease (MCD), Castleman Disease, Unicentric Castleman Disease (UCD), and Familial Colorectal Cancer. Dr. Mclain is currently accepting new patients.

As a gynecologic oncologist I strive to put the patient at the center of her multidisciplinary care and provide the most caring, leading-edge cancer treatments. Dr. Karam is highly rated in 48 conditions, according to our data. His top areas of expertise are Endometrial Cancer, Ovarian Cancer, Vulvar Cancer, Oophorectomy, and Hysterectomy.

Dr. Rebecca Olin is a hematologist who specializes in bone marrow transplantation in adults. Her expertise encompasses treating acute leukemia, myelodysplastic and myeloproliferative disorders (conditions in which the bone marrow makes too many white blood cells) and aplastic anemia (a condition in which the body doesn’t make enough new blood cells). In her research, Olin has a particular interest in studying how best to treat blood cancers in older patients, some of whom may require a bone marrow transplant. Olin earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania and was elected to the Alpha Omega Alpha Honor Medical Society. She completed a residency in internal medicine as well as a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, serving as chief fellow for one year. She also has a master's degree in clinical epidemiology, with a focus on medical decision making, from the University of Pennsylvania. Dr. Olin is highly rated in 31 conditions, according to our data. Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Pamela N. Munster is a medical oncologist who cares for patients with breast cancer. Her roles include director of the early-phase clinical trials program for cancer research; co-director of the UCSF Center for BRCA Research; and co-leader of UCSF's program in developmental therapeutics, which focuses on innovative research to find treatments for advanced cancer. In her own research endeavors, Munster is interested in developing new targeted therapies for treatment-resistant cancer. She studies changes in gene expression and resistance to therapy. Her lab is involved in projects evaluating hormone therapies for breast cancer as well as therapies that engage the immune system to fight tumors. She has published in numerous scientific journals and lectured on topics in breast oncology, such as the management of metastatic breast cancer, breast cancer receptors, clinical trials and translational research (the process of applying study findings to patient care). She has a published memoir, “Twisting Fate: My Journey with BRCA – From Breast Cancer Doctor to Patient and Back.” Munster earned her medical degree from the University of Bern in Switzerland. She completed a residency in internal medicine at Indiana University Health, followed by a fellowship in medical hematology and oncology at Memorial Sloan Kettering Cancer Center, where she also served as faculty in the breast cancer program. Prior to joining UCSF, Munster worked for six years in the Moffitt Cancer Center's division of breast oncology and experimental therapeutics program, serving as scientific director of breast research and co-chair of the phase 1 clinical trial program. Dr. Munster is highly rated in 29 conditions, according to our data. Her top areas of expertise are Breast Cancer, HER2 Negative Breast Cancer, Li-Fraumeni Syndrome, Prostatectomy, and Liver Embolization.

Ranjana Advani is an Oncologist in Palo Alto, California. Dr. Advani has been practicing medicine for over 44 years is highly rated in 29 conditions, according to our data. Her top areas of expertise are Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Tissue Biopsy.

Dr. Maxwell Meng is a surgeon specializing in urologic cancers and laparoscopy. His interests in patient care include diagnosing and managing cancers of the genital and urinary organs, as well as minimally invasive treatments of both benign and malignant diseases. He is experienced in robotic surgery. Meng is active in research to develop new treatment technologies. Meng earned his medical degree at Johns Hopkins School of Medicine. He completed general surgery and urology training at UCSF, where he also completed fellowships in urologic oncology and minimally invasive surgery. Dr. Meng is highly rated in 28 conditions, according to our data. His top areas of expertise are Bladder Cancer, Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Allison Kurian is an Oncologist in Palo Alto, California. Dr. Kurian is highly rated in 26 conditions, according to our data. Her top areas of expertise are Breast Cancer, Ovarian Cancer, Inflammatory Breast Cancer, Li-Fraumeni Syndrome, and Salpingo-Oophorectomy.

Dr. Alain Algazi is a specialist in medical treatment – such as chemotherapy and immunotherapy – for patients with head and neck cancers, including head and neck squamous cell carcinoma, thyroid cancers and salivary gland cancers. He leads UCSF's program in medical therapy for head and neck cancers, and chairs the head and neck cancer research committee. In research, Algazi conducts clinical trials – studies that evaluate new therapies for head and neck cancers with an emphasis on approaches to improving the chances of long term remission in patients with incurable cancer using immunotherapy. He has also served the national study chair for clinical trials that give patients access to new medications and that provide new approaches of administering existing medications to improve their efficacy. Algazi earned his medical degree from the David Geffen School of Medicine at UCLA and completed a residency in internal medicine at Ronald Reagan UCLA Medical Center. He completed a fellowship in hematology-oncology at UCSF. Algazi is a member of the American Society of Clinical Oncology, Society for Immunotherapy for Cancer and American Association for Cancer Research. To reach Dr. Alain Algazi, please contact the head and neck medical oncology practice at (415) 353-9900. Dr. Algazi is highly rated in 25 conditions, according to our data. His top areas of expertise are Melanoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Polymorphous Low Grade Adenocarcinoma, and Glioma.

Dr. Sima Porten is a specialist in cancers of the genital and urinary organs. She is a member of the urologic oncology team at the UCSF Helen Diller Family Comprehensive Cancer Center. Her clinical interests include the diagnosis and treatment of genitourinary cancer, particularly bladder cancer, upper tract urothelial cancer, kidney cancer and high-risk prostate cancer. Porten's research focuses mainly on the diagnosis and management of urothelial carcinoma, a cancer involving parts of the kidney, bladder and ureter (the tube connecting each kidney to the bladder). In studying the biologic or genetic basis of urothelial carcinoma, she hopes to develop new tests and treatments to bring personalized medicine to patients with bladder cancer. Porten received her undergraduate, medical and master of public health degrees from Northwestern University. During medical school, she was inducted into the Alpha Omega Alpha Honor Medical Society and also completed a fellowship through the Howard Hughes Medical Institute–National Institutes of Health Research Scholars Program. She then completed her urology residency training at UCSF, where she received the Julius R. Krevans Award for Clinical Excellence. During her training in urologic oncology at the University of Texas MD Anderson Cancer Center, she was awarded a John Quale Travel Fellowship for her research in bladder cancer. Porten is an active member of the American Urological Association, American Society of Clinical Oncology, Society of Women in Urology and Society of Urologic Oncology. Dr. Porten is highly rated in 20 conditions, according to our data. Her top areas of expertise are Bladder Cancer, Urothelial Cancer, Non-Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy.

Dr. Andrew H. Ko is a specialist in digestive system cancers. He provides compassionate and individualized care for patients with cancers of the pancreas, stomach and esophagus. In research, Ko has long been active in developing and evaluating new treatments for gastrointestinal cancers, including molecularly targeted agents and immune-based therapies. Ko earned an undergraduate degree in applied mathematics and biology at Brown University. He earned his medical degree at the Johns Hopkins University School of Medicine. He completed a residency in internal medicine at Beth Israel Deaconess Medical Center, an affiliate of Harvard Medical School, and completed a fellowship in medical oncology at Stanford University. He joined UCSF in 2001. Dr. Ko is highly rated in 20 conditions, according to our data. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Stomach Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Dr. Jennifer Perkins is an endocrinologist who specializes in endocrine neoplasia (tumors of hormone-producing glands, such as adrenal, thyroid and parathyroid tumors) with a focus in thyroid cancers and familial adrenal tumors. As co-director of UCSF's endocrine neoplasia program, she works with surgeons, radiation oncologists, medical oncologists and other endocrinologists to care for her patients. Perkins earned her medical degree at the Geisel School of Medicine at Dartmouth. She completed a residency in internal medicine at Virginia Commonwealth University Health and a fellowship in endocrinology at Vanderbilt University Medical Center. After completing her medical studies, she earned a master's degree in business administration at Duke University's Fuqua School of Business. Perkins has received numerous teaching awards and published many book chapters and articles on topics related to endocrine neoplasia. Dr. Perkins is highly rated in 19 conditions, according to our data. Her top areas of expertise are Thyroid Cancer, Follicular Thyroid Cancer, Anaplastic Thyroid Cancer, and Medullary Thyroid Carcinoma.

Hope Rugo is an Oncologist in San Francisco, California. Dr. Rugo is highly rated in 18 conditions, according to our data. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Agranulocytosis, Bone Marrow Aspiration, and Hormone Replacement Therapy (HRT).

John Chan is an Oncologist and an Obstetrics and Gynecologist in San Francisco, California. Dr. Chan is highly rated in 18 conditions, according to our data. His top areas of expertise are Adult Soft Tissue Sarcoma, Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Oophorectomy, and Bladder Reconstruction. Dr. Chan is currently accepting new patients.

Dr. Emily Bergsland is a gastrointestinal oncologist at the UCSF Helen Diller Family Comprehensive Cancer Center and the director of the UCSF Center for Neuroendocrine Tumors. She specializes in the multidisciplinary care of patients with neuroendocrine cancers. Bergsland's research is focused on better understanding why neuroendocrine tumors develop, identifying and testing new therapies, and improving outcomes in affected patients. Bergsland earned her medical degree at the University of Minnesota, then completed a residency in internal medicine and fellowship in medical oncology at UCSF. Dr. Bergsland is highly rated in 15 conditions, according to our data. Her top areas of expertise are Neuroendocrine Tumor, Carcinoid Syndrome, Pancreatic Islet Cell Tumor, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), and Hepatectomy.

Dr. Vadim S. Koshkin is a genitourinary oncologist who specializes in caring for adults with bladder, prostate, kidney and testicular cancers. His personal enthusiasm for travel informs his approach to care, as he likes to hear about where his patients come from in order to better understand who they are. In his research, Koshkin designs and carries out clinical trials of treatments for bladder and prostate cancers. He has a particular focus on the role of immunotherapy, or treatments that stimulate a patient's own immune system to help fight cancer. He also studies targeted treatments that are aimed against specific mutations in the DNA of tumor cells, which make these tumors more vulnerable to particular drugs. This allows for the delivery of personalized treatment based on individual characteristics of patients and their tumors. After earning his medical degree at the University of Chicago Pritzker School of Medicine, Koshkin completed a residency in internal medicine at the University of Michigan. He then completed a fellowship in hematology and oncology at the Cleveland Clinic. He belongs to the American Society of Clinical Oncology, American Association for Cancer Research and Bladder Cancer Advocacy Network. A history and trivia buff, Koshkin loves to read. He also follows soccer and Chicago sports teams in his free time. Dr. Koshkin is highly rated in 14 conditions, according to our data. His top areas of expertise are Urothelial Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Non-Muscle Invasive Bladder Cancer, and Lymphadenectomy.

Dr. Collin Blakely is a medical oncologist who specializes in lung cancer. In addition to treating patients, he conducts research focused on understanding the cellular and molecular mechanisms underlying lung cancer resistance to targeted therapies. His goal is to translate laboratory findings into new treatments. Blakely received his bachelor's degree in molecular and cellular biology from the University of Washington. He attended the Medical Scientist Training Program at the Perelman School of Medicine, earning both his medical and doctoral degrees. He completed his fellowship training in medical oncology at UCSF. Dr. Blakely is highly rated in 11 conditions, according to our data. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Lung Adenocarcinoma.

Christopher Dvorak is a Hematologist and an Oncologist in San Francisco, California. Dr. Dvorak is highly rated in 11 conditions, according to our data. His top areas of expertise are Severe Combined Immunodeficiency (SCID), Juvenile Myelomonocytic Leukemia (JMML), Hepatic Venoocclusive Disease with Immunodeficiency, Bone Marrow Transplant, and Splenectomy.

Priya Chakravarthi is an Oncologist in Palo Alto, California. Dr. Chakravarthi is highly rated in 11 conditions, according to our data. Her top areas of expertise are Myelodysplastic Syndrome (MDS), Inflammatory Breast Cancer, Breast Cancer, and Paget Disease of the Breast. Dr. Chakravarthi is currently accepting new patients.